Cargando…

High syphilis prevalence and incidence in people living with HIV and Preexposure Prophylaxis users: A retrospective review in the French Dat’AIDS cohort

BACKGROUND: In the past years, we observed a sharp increase of Syphilis, especially among male who have sex with male (MSM), either HIV-infected, or on pre-exposure prophylaxis (PrEP). Our aim was to assess syphilis prevalence and incidence among people living with HIV (PLWH) and PrEP users. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lemmet, Thomas, Cotte, Laurent, Allavena, Clotilde, Huleux, Thomas, Duvivier, Claudine, Laroche, Hélène, Cabie, André, Pugliese, Pascal, Jovelin, Thomas, Maurel, Marine, Delpierre, Cyrille, Rey, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119478/ https://www.ncbi.nlm.nih.gov/pubmed/35587482 http://dx.doi.org/10.1371/journal.pone.0268670

Ejemplares similares

Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score
por: Hentzien, Maxime, et al.
Publicado: (2018)

Pneumocystis jirovecii Pneumonia and Toxoplasmosis in PWH With HIV-Controlled Disease Treated for Solid Malignancies: A DAT’AIDS Study
por: Pansu, Nathalie, et al.
Publicado: (2022)

HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat’AIDS cohort
por: Hentzien, Maxime, et al.
Publicado: (2019)

Too fast to stay on track? Shorter time to first anti-retroviral regimen is not associated with better retention in care in the French Dat’AIDS cohort
por: Cuzin, L., et al.
Publicado: (2019)

Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015
por: Poizot‐Martin, I., et al.
Publicado: (2020)

Prevalence and Spectrum of Second Primary Malignancies among People Living with HIV in the French Dat’AIDS Cohort
por: Poizot-Martin, Isabelle, et al.
Publicado: (2022)

Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT’AIDS cohort
por: Lions, C., et al.
Publicado: (2019)

Determinants of Second Primary Cancer Type in Survivors of Virus-Related and Non-Virus-Related Cancer Living With HIV in the French Dat’AIDS Cohort
por: Poizot-Martin, Isabelle, et al.
Publicado: (2021)

Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection
por: Gantner, Pierre, et al.
Publicado: (2019)

Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study
por: Cuzin, Lise, et al.
Publicado: (2017)

Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study
por: Cotte, Laurent, et al.
Publicado: (2017)

First-line cART regimen impacts the course of CD8(+) T-cell counts in HIV-infected patients that achieve sustained undetectable viral load.
por: Poizot-Martin, Isabelle, et al.
Publicado: (2016)

Efficacy and tolerability of Etravirine in HIV-1 adult patients: Results of a large French prospective cohort
por: Allavena, Clotilde, et al.
Publicado: (2014)

Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients
por: Allavena, Clotilde, et al.
Publicado: (2018)

Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach
por: Cuzin, Lise, et al.
Publicado: (2015)

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
por: Virlogeux, Victor, et al.
Publicado: (2017)

Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France
por: Rojas Rojas, Teresa, et al.
Publicado: (2022)

Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study
por: de Boissieu, Paul, et al.
Publicado: (2016)

CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART
por: Poizot-Martin, Isabelle, et al.
Publicado: (2016)

The association of DAT gene methylation with striatal DAT availability in healthy subjects
por: Pak, Kyoungjune, et al.
Publicado: (2021)

The European preexposure prophylaxis revolution
por: Cairns, Gus, et al.
Publicado: (2016)

Test of DAT-DISP
Publicado: (1980)

Eligibility for HIV Preexposure Prophylaxis, Intention to Use Preexposure Prophylaxis, and Informal Use of Preexposure Prophylaxis Among Men Who Have Sex With Men in Amsterdam, the Netherlands
por: Hulstein, Sebastiaan H., et al.
Publicado: (2021)

Correction: The association of DAT gene methylation with striatal DAT availability in healthy subjects
por: Pak, Kyoungjune, et al.
Publicado: (2023)

Syphilis Predicts HIV Incidence Among Men and Transgender Women Who Have Sex With Men in a Preexposure Prophylaxis Trial
por: Solomon, Marc M., et al.
Publicado: (2014)

Effect of 6-Month HIV Preexposure Prophylaxis Dispensing With Interim Self-testing on Preexposure Prophylaxis Continuation at 12 Months: A Randomized Noninferiority Trial
por: Ortblad, Katrina F., et al.
Publicado: (2023)

Hepatitis C treatment initiation in HIV-HCV coinfected patients
por: Cotte, Laurent, et al.
Publicado: (2016)

The use of preexposure treatments for HIV prophylaxis
por: Majid, Adrian, et al.
Publicado: (2012)

Statistical issues in trials of preexposure prophylaxis
por: Dunn, David T., et al.
Publicado: (2016)

Dog bite, immunoglobulin, and preexposure vaccination
por: Pokee, Nora, et al.
Publicado: (2015)

Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice
por: Gantner, Pierre, et al.
Publicado: (2016)

Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV
por: Nguyen, Vinh-Kim, et al.
Publicado: (2018)

Risks and Benefits of Preexposure and Postexposure Smallpox Vaccination
por: Meltzer, Martin I.
Publicado: (2003)

Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women
por: Anderson, Peter L., et al.
Publicado: (2016)

Oral preexposure prophylaxis continuation, measurement and reporting
por: Stankevitz, Kayla, et al.
Publicado: (2020)

Cognitive decline in Huntington’s disease in the Digitalized Arithmetic Task (DAT)
por: Lunven, Marine, et al.
Publicado: (2021)

Wedden dat het gaat afkoelen
Publicado: (2009)

DaT Scan “Abnormality” in Hyperglycemic-Hemichorea
por: Doher, Nicholas, et al.
Publicado: (2019)

The effect of social deprivation on the dynamic of SARS-CoV-2 infection in France: a population-based analysis
por: Vandentorren, Stéphanie, et al.
Publicado: (2022)

Economic impact of generic antiretrovirals in France for HIV patients’ care: a simulation between 2019 and 2023
por: Demeulemeester, Romain, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_euq9rd4evdjvngp2skhm71bh11